[Treatment of heart rhythm disorders with beta-receptor-blocking agents].
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001146:Arrhythmia, Sinus / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000139:chemically induced / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000009:adverse effects; D006801:Humans; D009570:Nitriles / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014700:Verapamil
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D009570:Nitriles; D013565:Sympatholytics; D014665:Vasodilator Agents; D011433:Propranolol; D014700:Verapamil
Behandlung von Herzrhythmusstörungen mit beta-Rezeptorenblockern.